{"entity":{"id":"stitchpoint-bio","kind":"company","name":"Stitchpoint Bio","aka":[],"tldr":"Stitchpoint Bio is an Even One Ventures company outside cancer: antisense oligonucleotide medicines designed for a single rare disease patient's mutation, aiming to cut development from decades to months.","summary":"Stitchpoint Bio designs antisense oligonucleotide medicines matched to one patient's mutation, one sequence for one person, for the N-of-1 rare disease patients that conventional development leaves behind. It is a rare disease company in the Even One Ventures portfolio and does not work on cancer.","asOf":"2026-09-10","links":[{"label":"Official website","url":"https://stitchpoint.bio/"},{"label":"Even One Ventures portfolio","url":"https://evenone.ventures/"}],"tags":["startup","evenone-portfolio","rare-disease","non-oncology"],"related":[],"cancers":[],"sections":[],"technologies":["antisense-sirna"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"hq":"United States (head office not published)","country":"US","companyType":"biotech","website":"https://stitchpoint.bio/","stage":"startup","investors":["evenone-ventures"],"funding":[]},"route":"/companies/stitchpoint-bio/","neighbours":{"technology":[{"id":"antisense-sirna","kind":"technology","name":"Oligonucleotide therapeutics","route":"/technologies/antisense-sirna/"}],"company":[{"id":"evenone-ventures","kind":"company","name":"Even One Ventures","route":"/companies/evenone-ventures/"}]}}